This inventor holds 9 USPTO granted patents and 9 published patent applications. Top assignees: Omeros Corporation, Wilmington Savings Fund Society, Fsb, as Collateral Agent. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023-2026
Title: Innovator Spotlight: Markus Metz
Introduction:
Meet inventor Markus Metz, a talented innovator based in Bellevue, WA, who has made significant contributions in the field of MASP-2 inhibitors. Markus is a valuable asset to Omeros Corporation, where his inventive spirit shines through in his work.
Latest Patents:
Markus's latest patents revolve around MASP-2 inhibitors and methods of use. These innovative compounds exhibit MASP-2 inhibitory activity, opening new possibilities for treatments and therapies. Markus's dedication to developing these compounds underscores his commitment to driving advancements in the pharmaceutical industry.
Career Highlights:
With a portfolio of three patents to his name, Markus Metz has established himself as a notable figure in the world of inventions. His expertise in the development of MASP-2 inhibitors showcases his prowess in tackling complex scientific challenges. Markus's contributions have not only enhanced Omeros Corporation's reputation but have also propelled the company's research efforts forward.
Collaborations:
In his professional journey, Markus has collaborated with esteemed colleagues such as Neil S. Cutshall and Jennifer Lynn Gage. Together, they have harnessed their collective expertise to push the boundaries of innovation and produce groundbreaking solutions in the pharmaceutical arena. Markus values teamwork and recognizes the power of collaborative efforts in driving success.
Conclusion:
Markus Metz's relentless pursuit of excellence and his innovative mindset have positioned him as a frontrunner in the realm of MASP-2 inhibitors. Through his patents and collaborations, Markus continues to make a lasting impact on the field, shaping the future of pharmaceutical research. Keep an eye out for Markus Metz as he continues to lead the way in innovation and invention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile